NRIX
Nurix Therapeutics Inc
NASDAQ · Biotechnology
$16.85
+0.90 (+5.64%)
Open$16.29
Previous Close$15.95
Day High$17.03
Day Low$16.26
52W High$22.50
52W Low$8.18
Volume—
Avg Volume1.13M
Market Cap1.73B
P/E Ratio—
EPS$-3.04
SectorBiotechnology
Analyst Ratings
Strong Buy
23 analysts
Price Target
+329.0% upside
Current
$16.85
$16.85
Target
$72.29
$72.29
$45.76
$72.29 avg
$82.91
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 99.65M | 76.93M | 252.81M |
| Net Income | -313,815,175 | -218,028,143 | -27,375,633 |
| Profit Margin | -314.9% | -299.2% | -10.8% |
| EBITDA | -328,614,285 | -240,993,956 | -31,905,294 |
| Free Cash Flow | — | — | -23,615,781 |
| Rev Growth | +29.5% | +29.5% | -6.6% |
| Debt/Equity | — | — | 0.70 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |